Developer of oncology drugs designed to treat patients that target specific vulnerabilities of tumor cells. The company's oncology drugs are manufactured integrating insights from several fields of cell biology including DNA repair and synthetic lethality, enabling patients to have drugs that would improve cancer treatment both as single therapies and in combination with existing drugs and treatments. Read More